These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


73 related items for PubMed ID: 10072527

  • 1. Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes.
    Hsing Y, Bishop GA.
    J Immunol; 1999 Mar 01; 162(5):2804-11. PubMed ID: 10072527
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Suppression of IkappaBalpha expression is necessary for c-Jun N-terminal kinase-mediated enhancement of Fas cytotoxicity.
    Chang NS, Schultz L, Heath J.
    Biochem Biophys Res Commun; 2000 Jul 21; 274(1):4-10. PubMed ID: 10903887
    [Abstract] [Full Text] [Related]

  • 5. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
    Sutherland CL, Krebs DL, Gold MR.
    J Immunol; 1999 Apr 15; 162(8):4720-30. PubMed ID: 10202013
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
    Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA, Eliopoulos A, Hubscher SG, Young LS, Adams DH.
    FASEB J; 2001 Nov 15; 15(13):2345-54. PubMed ID: 11689460
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression.
    Natarajan K, Manna SK, Chaturvedi MM, Aggarwal BB.
    Arch Biochem Biophys; 1998 Apr 01; 352(1):59-70. PubMed ID: 9521814
    [Abstract] [Full Text] [Related]

  • 17. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
    Yang HJ, Wang L, Xia YY, Chang PN, Feng ZW.
    Neurochem Int; 2010 Jan 01; 56(1):128-34. PubMed ID: 19778565
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
    Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA.
    Hepatology; 2003 May 01; 37(5):1043-55. PubMed ID: 12717385
    [Abstract] [Full Text] [Related]

  • 19. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
    Schauer SL, Wang Z, Sonenshein GE, Rothstein TL.
    J Immunol; 1996 Jul 01; 157(1):81-6. PubMed ID: 8683159
    [Abstract] [Full Text] [Related]

  • 20. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK, Aggarwal BB.
    J Immunol; 1998 Sep 15; 161(6):2863-72. PubMed ID: 9743347
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.